New ReAct policy brief: Antimicrobial resistance and universal health coverage – What’s the deal?

  18 September 2019

Managing antibiotic resistance will be critical to achieve universal health coverage

Effective antibiotics are critically important cornerstones for a health system. Antimicrobial resistance would therefore seriously jeopardize the achievement of universal health coverage as:

  • Without sustainable and effective treatment of infections, good quality health care for all will not be reached.
  • Without management of antimicrobial resistance, sustainable financing of universal health coverage will be difficult.

Download Antimicrobial resistance and universal health coverage – What’s the deal?

Further reading: ReAct
Author(s): ReAct
Clean Environment   Effective Surveillance   Healthy Animals   Healthy Patients   Secure Foods  
Back


Boosting innovation to curb AMR?

AMR Innovation Mission UK 2021

 

The AMR Innovation Mission UK 2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development,  validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.

 

Read more and get involved >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!